Spinal StenosisERAS in SpineNCT06577389
Enhanced Recovery After Surgery for Spine Fusion Surgeries in the Elderly
An observational study of Spinal Stenosis, run by Sixth Affiliated Hospital of Xinjiang Medical University.
Trial summary
elderly patients in our hospital who received spinal fusion surgery after the year 2025 will receive ERAS treatment. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Spinal Stenosis
- What is being tested?
- Enhanced recovery after surgery
- How many people
- 1,500 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2025to 31 Dec 2028
- How long will I take part?
- 12 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: elderly patients who received spinal fusion surgeries
Who may be able to join
- elderly patients who received spinal fusion surgeries
Who cannot join
- patients who received non-fusion surgeries
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
elderly patients in our hospital who received spinal fusion surgery after the year 2025 will receive ERAS treatment.
- Conditions
- Spinal Stenosis
- Being tested
- Enhanced recovery after surgery
- Keywords
- spine fusion surgery
- Medical subject headings
- Spinal Stenosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Enhanced recovery after surgeryOther
The ERAS program for lumbar fusion surgery will be implemented.
| Study group | Role | What they receive |
|---|---|---|
| elderly after spine fusion surgery | patients receive Enhanced recovery after spinal fusion surgery Receives: Other: Enhanced recovery after surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
ambulation time
Measured: 7 days
Secondary outcomes (2)
mean hospital length of stay
Measured: one month
cost of hosptial stay
Measured: 1 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2024
- Study start1 Jan 2025 (estimated)
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal StenosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,500 participants (estimated)
- Target duration
- 12 Months
Sponsor and investigators
- Lead sponsor
- Sixth Affiliated Hospital of Xinjiang Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aikeremujiang Muheremu, Sixth Affiliated Hospital of Xinjiang Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06577389
- Sponsor's protocol ID
- SixthAHXinjiang
- Acronym
- ERAS in Spine
- Status last verified
- Aug 2024
- First submitted
- 27 Aug 2024
- Last updated
- 29 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: will decide before the year 2026
Study at a glance
From the registry record, last updated by the sponsor on 29 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Enhanced Recovery After Surgery for Spine Fusion Surgeries in the Elderly
- ClinicalTrials.gov ID
- NCT06577389
- Acronym / sponsor ID
- ERAS in Spine / SixthAHXinjiang
- Conditions
- Spinal Stenosis
- Keywords
- spine fusion surgery
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,500 participants (estimated)
- Lead sponsor
- Sixth Affiliated Hospital of Xinjiang Medical UniversityUniversity, hospital or other
- Study start
- 1 Jan 2025 (estimated)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 29 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
elderly patients in our hospital who received spinal fusion surgery after the year 2025 will receive ERAS treatment.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 12 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| elderly after spine fusion surgery | – | Other: Enhanced recovery after surgerypatients receive Enhanced recovery after spinal fusion surgery |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- elderly patients who received spinal fusion surgeries
Key inclusion criteria (1 listed)
- elderly patients who received spinal fusion surgeries
Key exclusion criteria (1 listed)
- patients who received non-fusion surgeries
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Enhanced recovery after surgeryThe ERAS program for lumbar fusion surgery will be implemented. | Other | elderly after spine fusion surgery |
Primary outcome
ambulation time
Time frame: 7 days
2 secondary outcomes
mean hospital length of stay
Time frame: one month
cost of hosptial stay
Time frame: 1 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Aug 2024.
- Individual participant dataSharing planned: Undecided. will decide before the year 2026
Related trials for Spinal Stenosis
Not yet recruitingObservational study
Foraminal Imaging and Symptoms in Single-Level Degenerative Lumbar Stenosis
Degenerative Lumbar Spinal Stenosis, Lumbar Foraminal Stenosis
Recruiting
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Degenerative Conditions of the Lumbar Spine, Lumbar Spinal Stenosis
RecruitingObservational study
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
Active, not recruitingPhase 3
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
Melanoma, Ovarian Cancer
RecruitingObservational study
Thoracic-Lumbar Arthrodesis- Implanet Jazz
Spondylolisthesis, Spinal Stenosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Spinal Stenosis, run by Sixth Affiliated Hospital of Xinjiang Medical University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aikeremujiang Professor Ai (+8618810914750, muheremua@bjmu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ambulation time (time frame: 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2024.